Literature DB >> 17574402

In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use.

S Lombardi Borgia1, P Schlupp, W Mehnert, M Schäfer-Korting.   

Abstract

Reconstructed human epidermis is a useful tool for in vitro skin absorption studies of chemical compounds. If this may hold true also for topical dermatics, we investigated the glucocorticoid prednicarbate applied by two sets (innovator and generic) of cream, ointment and fatty ointment using the commercially available EpiDerm model. Moreover, stability and local tolerability of the preparations as well as drug release were studied, to estimate an influence on prednicarbate absorption and metabolism. While release ranked in the order cream<fatty ointment<ointment for both sets of preparations, prednicarbate penetration and permeation of the EpiDerm model did not. Less PC uptake observed with the generic ointment and fatty ointment appeared to be linked to impaired enzymatic ester cleavage within the tissue. Thus with drugs subject to skin metabolism, cutaneous uptake is not to be derived from drug release studies, yet has to be studied experimentally with viable skin or reconstructed human epidermis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574402     DOI: 10.1016/j.ejpb.2007.05.003

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  2 in total

1.  Elucidating the Skin Delivery of Aglycone and Glycoside Flavonoids: How the Structures Affect Cutaneous Absorption.

Authors:  Shih-Yi Chuang; Yin-Ku Lin; Chwan-Fwu Lin; Pei-Wen Wang; En-Li Chen; Jia-You Fang
Journal:  Nutrients       Date:  2017-11-30       Impact factor: 5.717

2.  Reconstructed Human Epidermis: An Alternative Approach for In Vitro Bioequivalence Testing of Topical Products.

Authors:  Ana Sofia Agonia; Ana Palmeira-de-Oliveira; Catarina Cardoso; Cátia Augusto; Christian Pellevoisin; Christelle Videau; Ricardo Jorge Dinis-Oliveira; Rita Palmeira-de-Oliveira
Journal:  Pharmaceutics       Date:  2022-07-26       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.